Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
about
Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy.Skeletal Muscle Involvement in Antisynthetase Syndrome.Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.Idiopathic inflammatory myopathies overlapping with systemic diseases.Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.Muscle Magnetic Resonance Imaging for the Differentiation of Multiple Acyl-CoA Dehydrogenase Deficiency and Immune-mediated Necrotizing Myopathy.Diffuse microvascular C5b-9 deposition is a common feature in muscle and nerve biopsies from diabetic patients.More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Immune-Mediated Necrotizing Myopathy.Necrotizing Autoimmune Myopathy: Clinicopathologic Study from a Single Tertiary Care Centre.Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy
P2860
Q33620443-13A1E4F9-D0E7-44D4-9625-D968C2BFF80AQ37324573-87FFF952-24DF-4880-AE9B-40FDCE748A43Q38740583-E0E81DA0-30AB-41B7-A206-6D12F62FE5FEQ38948633-C5344C57-116D-4629-951E-5DCA6350F29DQ41308116-B41704D7-D848-4B21-9137-872A3155F67EQ41590349-D92EC534-FFF5-4B7B-B1C8-B00375AA03BBQ45969468-01CA66A7-7817-49F5-878E-E15D731AE78AQ47401892-202FBDE1-3EE4-4C9D-A0B3-CE6DFAE57DD9Q47988184-3F346935-4C9C-462C-BA15-D28E710C1A29Q49322711-873F29B3-4B5C-477E-BA5F-F7EB9C2B64A8Q49842991-2C25E655-7704-4C9A-88FB-C99D4324AE48Q50948932-6C1F9730-6A90-4C01-B317-CCFE5AB39115Q52597638-379B562B-50DB-4CA4-9CCD-12C33857C287Q52628910-427C7A70-206A-46C7-B539-90973A01F975Q55078027-714D2469-63C8-4D27-A9B7-803D425F055BQ57814497-718952A0-CED9-491D-B876-AA3FAF97FE00
P2860
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
@en
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
@nl
type
label
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
@en
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
@nl
prefLabel
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
@en
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
@nl
P2093
P2860
P356
P1476
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
@en
P2093
Akinori Uruha
Jin Nakahara
Kazuko Takayama
Kohei Hamanaka
Norihiro Suzuki
Shigeaki Suzuki
Yurika Watanabe
P2860
P304
P356
10.1136/JNNP-2016-313166
P407
P577
2016-05-04T00:00:00Z